China approves first self-developed COVID-19 vaccine - People s Daily Online en.people.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.people.cn Daily Mail and Mail on Sunday newspapers.
2021-01-01 14:26:32 GMT2021-01-01 22:26:32(Beijing Time) Xinhua English
A staff member checks a COVID-19 inactivated vaccine product at a packaging plant of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, Dec. 25, 2020. (Xinhua/Zhang Yuwei)
BEIJING, Jan. 1 (Xinhua) The Chinese word for crisis (wei ji) is composed of two characters: danger (wei) and opportunity (ji), and the wisdom to avert a crisis is always somewhere in between.
As the new year kicks off, the very danger from 2020 has largely departed China, where the extraordinary year ended with a newly-approved vaccine a further step to tame the pandemic and the completion of investment agreement negotiations with the European Union a boost to world economic recovery.
CHINA approved its first homegrown COVID-19 vaccine for general public use yesterday, and vowed to provide free vaccines to all its citizens, marking a major stride toward inoculating the world’s largest
First Self-developed COVID-19 Vaccine
China has approved the first self-developed coronavirus vaccine. The inactivated vaccine, which got approval from the National Medical Products Administration (NMPA), is developed by the Beijing Biological Products Institute Co., Ltd. under the China National Biotec Group (CNBG), affiliated with Sinopharm.
The interim results of its phase-3 clinical trials show 79.34 per cent efficacy against Covid-19, meeting the standards of the World Health Organization and the NMPA, according to a press conference by the State Council joint prevention and control mechanism against Covid-19, the Xinhua news agency reported.
Chen Shifei, deputy head of the NMPA, said that the conditional approval was granted according to relevant laws.
Covid-19: China approves first self-developed vaccine
IANS/Beijing
Reuters
China announced that it had granted conditional marketing authorisation for the first Covid-19 vaccine.
The inactivated vaccine, which got approval from the National Medical Products Administration (NMPA), is developed by the Beijing Biological Products Institute Co., Ltd. under the China National Biotec Group (CNBG), affiliated with Sinopharm.
The interim results of its phase-3 clinical trials show 79.34 per cent efficacy against Covid-19, meeting the standards of the World Health Organization and the NMPA, according to a press conference by the State Council joint prevention and control mechanism against Covid-19, the Xinhua news agency reported.